AMS.L - Advanced Medical Solutions Group plc

LSE - LSE Delayed Price. Currency in GBp

Advanced Medical Solutions Group plc

Premier Park
33 Road One Winsford Industrial Estate
Winsford CW7 3RT
United Kingdom
44 1606 863 500

IndustryMedical Instruments & Supplies
Full Time Employees674

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew Christopher MeredithCEO & Exec. DirectorN/AN/A1967
Ms. Mary G. Tavener ACMA, BA (Hons), MCTFin. Director, Company Sec. & DirectorN/AN/A1962
Mr. Pieter van Hoof MEngGroup Operations DirectorN/AN/A1973
Ms. Cathy TomlinsonGroup HR DirectorN/AN/AN/A
Brian DowdHead of US Commercial TeamN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the advanced wound care, surgical, and wound closure markets worldwide. It operates through two segments, Branded and OEM. The company offers natural and synthetic polymers for use in advanced wound care dressings under the ActivHeal brand; medical adhesives for closing and sealing tissue under the LiquiBand brand name; and sutures and haemostats for the medical device market under the RESORBA brand. It also provides advanced wound care products and bulk materials to business-to-business partners and third party convertors. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.

Corporate Governance

Advanced Medical Solutions Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.